Safety and Effectiveness Study of Tocilizumab in Patients With Severe COVID-19
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Tocilizumab
Related studies linked through entity extraction aliases.
A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Effect of Tocilizumab on Intensive Care Patients With COVID-19 Pneumonia, a Retrospective Cohort Study
- Status
- COMPLETED
- Phase
- N/A
Efficacy of Tocilizumab in Association to Steroids in Giant Cell Arteritis With Cerebro-vascular Involvement
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Evaluating Tocilizumab for Sever COVID-19 Infection in Breast Cancer vs. Non Cancer Pateints
- Status
- COMPLETED
- Phase
- PHASE2
Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis
- Status
- RECRUITING
- Phase
- PHASE3
Interleukin-6 Inhibitors and Drug-drug Interactions in Patients With Rheumatoid Arthritis
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Evaluation of the Safety of Use of Anti-IL6 Receptor Antibodies to Reduce Allo-sensitization Post Allograft Nephrectomy
- Status
- COMPLETED
- Phase
- PHASE2
Comparative Therapeutic Efficacy and Safety of Different Antiviral and Anti Inflammatory Drugs in COVID-19 Patients.
- Status
- UNKNOWN
- Phase
- PHASE4
A Prospective Study of Tocilizumab in the Treatment of Idiopathic Retroperitoneal Fibrosis
- Status
- UNKNOWN
- Phase
- PHASE4
Comparison of Tocilizumab Versus Tocilizumab/Infliximab in Patients With COVID-19-associated Cytokine Storm Syndrome
- Status
- COMPLETED
- Phase
- N/A
TOCILIZUMAB - An Option for Patients With COVID-19 Associated Cytokine Release Syndrome; A Single Center Experience
- Status
- COMPLETED
- Phase
- PHASE4
Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Efficacy of Ramdicivir and Baricitinib for the Treatment of Severe COVID 19 Patients
- Status
- UNKNOWN
- Phase
- PHASE3
Tocilizumab and Atezolizumab in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Refractory to 1st Line Immune Checkpoint Inhibitor-Based Therapy
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Theranostic Implication of Complementary Medicines Against Interleukin Receptors and Gp-130 Proteins
- Status
- COMPLETED
- Phase
- NA
A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT.
- Status
- UNKNOWN
- Phase
- PHASE2
Meal-regulated Substrate Metabolism, Influence of Obesity and IL-6
- Status
- COMPLETED
- Phase
- NA
Efficacy and Safety of Remdesivir and Tociluzumab for the Management of Severe COVID-19: A Randomized Controlled Trial
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate Glofitamab as Single Agent Administered After Pretreatment With Obinutuzumab in Chinese Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1